Mean recurrence-free survival was 37 ± 2 months among patients achieving TO versus 35 ± 2 months among non-achievers, a difference that did not reach statistical significance p = 0.34.
← all excerpts
The textbook outcome of pancreaticoduodenectomy for adenocarcinoma of the pancreas in a high-volume centre.
1
0.3400
0.3400